Medical Care
Global Anal and Colorectal Cancer Market Research Report 2025
- Sep 06, 25
- ID: 492841
- Pages: 98
- Figures: 98
- Views: 7
This report aims to provide a comprehensive presentation of the global market for Anal and Colorectal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anal and Colorectal Cancer.
The Anal and Colorectal Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anal and Colorectal Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anal and Colorectal Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
Advaxis
Abbott
Amgen
Atara Biotherapeutics
Bayer
Metabiomics
Beckman Coulter
BeiGene
Boehringer Ingelheim
Clinical Genomics
EDP Biotech
Eli Lilly
Epigenomics
Exact Sciences
Genomictree
Immunovaccine
ISA Pharmaceuticals
Merck
Segment by Type
Surgery
Radiation therapy
Colorectal cancer chemotherapy
Targeted therapy
Immunotherapy
Segment by Application
Hospitals
Ambulatory surgery centers
Cancer research centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anal and Colorectal Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Anal and Colorectal Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anal and Colorectal Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anal and Colorectal Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
Advaxis
Abbott
Amgen
Atara Biotherapeutics
Bayer
Metabiomics
Beckman Coulter
BeiGene
Boehringer Ingelheim
Clinical Genomics
EDP Biotech
Eli Lilly
Epigenomics
Exact Sciences
Genomictree
Immunovaccine
ISA Pharmaceuticals
Merck
Segment by Type
Surgery
Radiation therapy
Colorectal cancer chemotherapy
Targeted therapy
Immunotherapy
Segment by Application
Hospitals
Ambulatory surgery centers
Cancer research centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anal and Colorectal Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anal and Colorectal Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Surgery
1.2.3 Radiation therapy
1.2.4 Colorectal cancer chemotherapy
1.2.5 Targeted therapy
1.2.6 Immunotherapy
1.3 Market by Application
1.3.1 Global Anal and Colorectal Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory surgery centers
1.3.4 Cancer research centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anal and Colorectal Cancer Market Perspective (2020-2031)
2.2 Global Anal and Colorectal Cancer Growth Trends by Region
2.2.1 Global Anal and Colorectal Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anal and Colorectal Cancer Historic Market Size by Region (2020-2025)
2.2.3 Anal and Colorectal Cancer Forecasted Market Size by Region (2026-2031)
2.3 Anal and Colorectal Cancer Market Dynamics
2.3.1 Anal and Colorectal Cancer Industry Trends
2.3.2 Anal and Colorectal Cancer Market Drivers
2.3.3 Anal and Colorectal Cancer Market Challenges
2.3.4 Anal and Colorectal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anal and Colorectal Cancer Players by Revenue
3.1.1 Global Top Anal and Colorectal Cancer Players by Revenue (2020-2025)
3.1.2 Global Anal and Colorectal Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Anal and Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anal and Colorectal Cancer Revenue
3.4 Global Anal and Colorectal Cancer Market Concentration Ratio
3.4.1 Global Anal and Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anal and Colorectal Cancer Revenue in 2024
3.5 Global Key Players of Anal and Colorectal Cancer Head office and Area Served
3.6 Global Key Players of Anal and Colorectal Cancer, Product and Application
3.7 Global Key Players of Anal and Colorectal Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anal and Colorectal Cancer Breakdown Data by Type
4.1 Global Anal and Colorectal Cancer Historic Market Size by Type (2020-2025)
4.2 Global Anal and Colorectal Cancer Forecasted Market Size by Type (2026-2031)
5 Anal and Colorectal Cancer Breakdown Data by Application
5.1 Global Anal and Colorectal Cancer Historic Market Size by Application (2020-2025)
5.2 Global Anal and Colorectal Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anal and Colorectal Cancer Market Size (2020-2031)
6.2 North America Anal and Colorectal Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anal and Colorectal Cancer Market Size by Country (2020-2025)
6.4 North America Anal and Colorectal Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anal and Colorectal Cancer Market Size (2020-2031)
7.2 Europe Anal and Colorectal Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anal and Colorectal Cancer Market Size by Country (2020-2025)
7.4 Europe Anal and Colorectal Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anal and Colorectal Cancer Market Size (2020-2031)
8.2 Asia-Pacific Anal and Colorectal Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anal and Colorectal Cancer Market Size (2020-2031)
9.2 Latin America Anal and Colorectal Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anal and Colorectal Cancer Market Size by Country (2020-2025)
9.4 Latin America Anal and Colorectal Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anal and Colorectal Cancer Market Size (2020-2031)
10.2 Middle East & Africa Anal and Colorectal Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Anal and Colorectal Cancer Introduction
11.1.4 Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.1.5 Abbott Diagnostics Recent Development
11.2 Advaxis
11.2.1 Advaxis Company Details
11.2.2 Advaxis Business Overview
11.2.3 Advaxis Anal and Colorectal Cancer Introduction
11.2.4 Advaxis Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.2.5 Advaxis Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Anal and Colorectal Cancer Introduction
11.3.4 Abbott Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Anal and Colorectal Cancer Introduction
11.4.4 Amgen Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.4.5 Amgen Recent Development
11.5 Atara Biotherapeutics
11.5.1 Atara Biotherapeutics Company Details
11.5.2 Atara Biotherapeutics Business Overview
11.5.3 Atara Biotherapeutics Anal and Colorectal Cancer Introduction
11.5.4 Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.5.5 Atara Biotherapeutics Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Anal and Colorectal Cancer Introduction
11.6.4 Bayer Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.6.5 Bayer Recent Development
11.7 Metabiomics
11.7.1 Metabiomics Company Details
11.7.2 Metabiomics Business Overview
11.7.3 Metabiomics Anal and Colorectal Cancer Introduction
11.7.4 Metabiomics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.7.5 Metabiomics Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Anal and Colorectal Cancer Introduction
11.8.4 Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.8.5 Beckman Coulter Recent Development
11.9 BeiGene
11.9.1 BeiGene Company Details
11.9.2 BeiGene Business Overview
11.9.3 BeiGene Anal and Colorectal Cancer Introduction
11.9.4 BeiGene Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.9.5 BeiGene Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Details
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Anal and Colorectal Cancer Introduction
11.10.4 Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.10.5 Boehringer Ingelheim Recent Development
11.11 Clinical Genomics
11.11.1 Clinical Genomics Company Details
11.11.2 Clinical Genomics Business Overview
11.11.3 Clinical Genomics Anal and Colorectal Cancer Introduction
11.11.4 Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.11.5 Clinical Genomics Recent Development
11.12 EDP Biotech
11.12.1 EDP Biotech Company Details
11.12.2 EDP Biotech Business Overview
11.12.3 EDP Biotech Anal and Colorectal Cancer Introduction
11.12.4 EDP Biotech Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.12.5 EDP Biotech Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Anal and Colorectal Cancer Introduction
11.13.4 Eli Lilly Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.13.5 Eli Lilly Recent Development
11.14 Epigenomics
11.14.1 Epigenomics Company Details
11.14.2 Epigenomics Business Overview
11.14.3 Epigenomics Anal and Colorectal Cancer Introduction
11.14.4 Epigenomics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.14.5 Epigenomics Recent Development
11.15 Exact Sciences
11.15.1 Exact Sciences Company Details
11.15.2 Exact Sciences Business Overview
11.15.3 Exact Sciences Anal and Colorectal Cancer Introduction
11.15.4 Exact Sciences Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.15.5 Exact Sciences Recent Development
11.16 Genomictree
11.16.1 Genomictree Company Details
11.16.2 Genomictree Business Overview
11.16.3 Genomictree Anal and Colorectal Cancer Introduction
11.16.4 Genomictree Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.16.5 Genomictree Recent Development
11.17 Immunovaccine
11.17.1 Immunovaccine Company Details
11.17.2 Immunovaccine Business Overview
11.17.3 Immunovaccine Anal and Colorectal Cancer Introduction
11.17.4 Immunovaccine Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.17.5 Immunovaccine Recent Development
11.18 ISA Pharmaceuticals
11.18.1 ISA Pharmaceuticals Company Details
11.18.2 ISA Pharmaceuticals Business Overview
11.18.3 ISA Pharmaceuticals Anal and Colorectal Cancer Introduction
11.18.4 ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.18.5 ISA Pharmaceuticals Recent Development
11.19 Merck
11.19.1 Merck Company Details
11.19.2 Merck Business Overview
11.19.3 Merck Anal and Colorectal Cancer Introduction
11.19.4 Merck Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.19.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anal and Colorectal Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Surgery
1.2.3 Radiation therapy
1.2.4 Colorectal cancer chemotherapy
1.2.5 Targeted therapy
1.2.6 Immunotherapy
1.3 Market by Application
1.3.1 Global Anal and Colorectal Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory surgery centers
1.3.4 Cancer research centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anal and Colorectal Cancer Market Perspective (2020-2031)
2.2 Global Anal and Colorectal Cancer Growth Trends by Region
2.2.1 Global Anal and Colorectal Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anal and Colorectal Cancer Historic Market Size by Region (2020-2025)
2.2.3 Anal and Colorectal Cancer Forecasted Market Size by Region (2026-2031)
2.3 Anal and Colorectal Cancer Market Dynamics
2.3.1 Anal and Colorectal Cancer Industry Trends
2.3.2 Anal and Colorectal Cancer Market Drivers
2.3.3 Anal and Colorectal Cancer Market Challenges
2.3.4 Anal and Colorectal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anal and Colorectal Cancer Players by Revenue
3.1.1 Global Top Anal and Colorectal Cancer Players by Revenue (2020-2025)
3.1.2 Global Anal and Colorectal Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Anal and Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anal and Colorectal Cancer Revenue
3.4 Global Anal and Colorectal Cancer Market Concentration Ratio
3.4.1 Global Anal and Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anal and Colorectal Cancer Revenue in 2024
3.5 Global Key Players of Anal and Colorectal Cancer Head office and Area Served
3.6 Global Key Players of Anal and Colorectal Cancer, Product and Application
3.7 Global Key Players of Anal and Colorectal Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anal and Colorectal Cancer Breakdown Data by Type
4.1 Global Anal and Colorectal Cancer Historic Market Size by Type (2020-2025)
4.2 Global Anal and Colorectal Cancer Forecasted Market Size by Type (2026-2031)
5 Anal and Colorectal Cancer Breakdown Data by Application
5.1 Global Anal and Colorectal Cancer Historic Market Size by Application (2020-2025)
5.2 Global Anal and Colorectal Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anal and Colorectal Cancer Market Size (2020-2031)
6.2 North America Anal and Colorectal Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anal and Colorectal Cancer Market Size by Country (2020-2025)
6.4 North America Anal and Colorectal Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anal and Colorectal Cancer Market Size (2020-2031)
7.2 Europe Anal and Colorectal Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anal and Colorectal Cancer Market Size by Country (2020-2025)
7.4 Europe Anal and Colorectal Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anal and Colorectal Cancer Market Size (2020-2031)
8.2 Asia-Pacific Anal and Colorectal Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anal and Colorectal Cancer Market Size (2020-2031)
9.2 Latin America Anal and Colorectal Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anal and Colorectal Cancer Market Size by Country (2020-2025)
9.4 Latin America Anal and Colorectal Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anal and Colorectal Cancer Market Size (2020-2031)
10.2 Middle East & Africa Anal and Colorectal Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Anal and Colorectal Cancer Introduction
11.1.4 Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.1.5 Abbott Diagnostics Recent Development
11.2 Advaxis
11.2.1 Advaxis Company Details
11.2.2 Advaxis Business Overview
11.2.3 Advaxis Anal and Colorectal Cancer Introduction
11.2.4 Advaxis Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.2.5 Advaxis Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Anal and Colorectal Cancer Introduction
11.3.4 Abbott Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Anal and Colorectal Cancer Introduction
11.4.4 Amgen Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.4.5 Amgen Recent Development
11.5 Atara Biotherapeutics
11.5.1 Atara Biotherapeutics Company Details
11.5.2 Atara Biotherapeutics Business Overview
11.5.3 Atara Biotherapeutics Anal and Colorectal Cancer Introduction
11.5.4 Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.5.5 Atara Biotherapeutics Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Anal and Colorectal Cancer Introduction
11.6.4 Bayer Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.6.5 Bayer Recent Development
11.7 Metabiomics
11.7.1 Metabiomics Company Details
11.7.2 Metabiomics Business Overview
11.7.3 Metabiomics Anal and Colorectal Cancer Introduction
11.7.4 Metabiomics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.7.5 Metabiomics Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Anal and Colorectal Cancer Introduction
11.8.4 Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.8.5 Beckman Coulter Recent Development
11.9 BeiGene
11.9.1 BeiGene Company Details
11.9.2 BeiGene Business Overview
11.9.3 BeiGene Anal and Colorectal Cancer Introduction
11.9.4 BeiGene Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.9.5 BeiGene Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Details
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Anal and Colorectal Cancer Introduction
11.10.4 Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.10.5 Boehringer Ingelheim Recent Development
11.11 Clinical Genomics
11.11.1 Clinical Genomics Company Details
11.11.2 Clinical Genomics Business Overview
11.11.3 Clinical Genomics Anal and Colorectal Cancer Introduction
11.11.4 Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.11.5 Clinical Genomics Recent Development
11.12 EDP Biotech
11.12.1 EDP Biotech Company Details
11.12.2 EDP Biotech Business Overview
11.12.3 EDP Biotech Anal and Colorectal Cancer Introduction
11.12.4 EDP Biotech Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.12.5 EDP Biotech Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Anal and Colorectal Cancer Introduction
11.13.4 Eli Lilly Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.13.5 Eli Lilly Recent Development
11.14 Epigenomics
11.14.1 Epigenomics Company Details
11.14.2 Epigenomics Business Overview
11.14.3 Epigenomics Anal and Colorectal Cancer Introduction
11.14.4 Epigenomics Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.14.5 Epigenomics Recent Development
11.15 Exact Sciences
11.15.1 Exact Sciences Company Details
11.15.2 Exact Sciences Business Overview
11.15.3 Exact Sciences Anal and Colorectal Cancer Introduction
11.15.4 Exact Sciences Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.15.5 Exact Sciences Recent Development
11.16 Genomictree
11.16.1 Genomictree Company Details
11.16.2 Genomictree Business Overview
11.16.3 Genomictree Anal and Colorectal Cancer Introduction
11.16.4 Genomictree Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.16.5 Genomictree Recent Development
11.17 Immunovaccine
11.17.1 Immunovaccine Company Details
11.17.2 Immunovaccine Business Overview
11.17.3 Immunovaccine Anal and Colorectal Cancer Introduction
11.17.4 Immunovaccine Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.17.5 Immunovaccine Recent Development
11.18 ISA Pharmaceuticals
11.18.1 ISA Pharmaceuticals Company Details
11.18.2 ISA Pharmaceuticals Business Overview
11.18.3 ISA Pharmaceuticals Anal and Colorectal Cancer Introduction
11.18.4 ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.18.5 ISA Pharmaceuticals Recent Development
11.19 Merck
11.19.1 Merck Company Details
11.19.2 Merck Business Overview
11.19.3 Merck Anal and Colorectal Cancer Introduction
11.19.4 Merck Revenue in Anal and Colorectal Cancer Business (2020-2025)
11.19.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anal and Colorectal Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation therapy
Table 4. Key Players of Colorectal cancer chemotherapy
Table 5. Key Players of Targeted therapy
Table 6. Key Players of Immunotherapy
Table 7. Global Anal and Colorectal Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Anal and Colorectal Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Anal and Colorectal Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Anal and Colorectal Cancer Market Share by Region (2020-2025)
Table 11. Global Anal and Colorectal Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Anal and Colorectal Cancer Market Share by Region (2026-2031)
Table 13. Anal and Colorectal Cancer Market Trends
Table 14. Anal and Colorectal Cancer Market Drivers
Table 15. Anal and Colorectal Cancer Market Challenges
Table 16. Anal and Colorectal Cancer Market Restraints
Table 17. Global Anal and Colorectal Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Anal and Colorectal Cancer Market Share by Players (2020-2025)
Table 19. Global Top Anal and Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anal and Colorectal Cancer as of 2024)
Table 20. Ranking of Global Top Anal and Colorectal Cancer Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Anal and Colorectal Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Anal and Colorectal Cancer, Headquarters and Area Served
Table 23. Global Key Players of Anal and Colorectal Cancer, Product and Application
Table 24. Global Key Players of Anal and Colorectal Cancer, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anal and Colorectal Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Anal and Colorectal Cancer Revenue Market Share by Type (2020-2025)
Table 28. Global Anal and Colorectal Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Anal and Colorectal Cancer Revenue Market Share by Type (2026-2031)
Table 30. Global Anal and Colorectal Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Anal and Colorectal Cancer Revenue Market Share by Application (2020-2025)
Table 32. Global Anal and Colorectal Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Anal and Colorectal Cancer Revenue Market Share by Application (2026-2031)
Table 34. North America Anal and Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Anal and Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Anal and Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Anal and Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Anal and Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Anal and Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Anal and Colorectal Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Anal and Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Anal and Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Anal and Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Anal and Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abbott Diagnostics Company Details
Table 50. Abbott Diagnostics Business Overview
Table 51. Abbott Diagnostics Anal and Colorectal Cancer Product
Table 52. Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 53. Abbott Diagnostics Recent Development
Table 54. Advaxis Company Details
Table 55. Advaxis Business Overview
Table 56. Advaxis Anal and Colorectal Cancer Product
Table 57. Advaxis Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 58. Advaxis Recent Development
Table 59. Abbott Company Details
Table 60. Abbott Business Overview
Table 61. Abbott Anal and Colorectal Cancer Product
Table 62. Abbott Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 63. Abbott Recent Development
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Anal and Colorectal Cancer Product
Table 67. Amgen Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. Atara Biotherapeutics Company Details
Table 70. Atara Biotherapeutics Business Overview
Table 71. Atara Biotherapeutics Anal and Colorectal Cancer Product
Table 72. Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 73. Atara Biotherapeutics Recent Development
Table 74. Bayer Company Details
Table 75. Bayer Business Overview
Table 76. Bayer Anal and Colorectal Cancer Product
Table 77. Bayer Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 78. Bayer Recent Development
Table 79. Metabiomics Company Details
Table 80. Metabiomics Business Overview
Table 81. Metabiomics Anal and Colorectal Cancer Product
Table 82. Metabiomics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 83. Metabiomics Recent Development
Table 84. Beckman Coulter Company Details
Table 85. Beckman Coulter Business Overview
Table 86. Beckman Coulter Anal and Colorectal Cancer Product
Table 87. Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 88. Beckman Coulter Recent Development
Table 89. BeiGene Company Details
Table 90. BeiGene Business Overview
Table 91. BeiGene Anal and Colorectal Cancer Product
Table 92. BeiGene Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 93. BeiGene Recent Development
Table 94. Boehringer Ingelheim Company Details
Table 95. Boehringer Ingelheim Business Overview
Table 96. Boehringer Ingelheim Anal and Colorectal Cancer Product
Table 97. Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 98. Boehringer Ingelheim Recent Development
Table 99. Clinical Genomics Company Details
Table 100. Clinical Genomics Business Overview
Table 101. Clinical Genomics Anal and Colorectal Cancer Product
Table 102. Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 103. Clinical Genomics Recent Development
Table 104. EDP Biotech Company Details
Table 105. EDP Biotech Business Overview
Table 106. EDP Biotech Anal and Colorectal Cancer Product
Table 107. EDP Biotech Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 108. EDP Biotech Recent Development
Table 109. Eli Lilly Company Details
Table 110. Eli Lilly Business Overview
Table 111. Eli Lilly Anal and Colorectal Cancer Product
Table 112. Eli Lilly Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 113. Eli Lilly Recent Development
Table 114. Epigenomics Company Details
Table 115. Epigenomics Business Overview
Table 116. Epigenomics Anal and Colorectal Cancer Product
Table 117. Epigenomics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 118. Epigenomics Recent Development
Table 119. Exact Sciences Company Details
Table 120. Exact Sciences Business Overview
Table 121. Exact Sciences Anal and Colorectal Cancer Product
Table 122. Exact Sciences Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 123. Exact Sciences Recent Development
Table 124. Genomictree Company Details
Table 125. Genomictree Business Overview
Table 126. Genomictree Anal and Colorectal Cancer Product
Table 127. Genomictree Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 128. Genomictree Recent Development
Table 129. Immunovaccine Company Details
Table 130. Immunovaccine Business Overview
Table 131. Immunovaccine Anal and Colorectal Cancer Product
Table 132. Immunovaccine Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 133. Immunovaccine Recent Development
Table 134. ISA Pharmaceuticals Company Details
Table 135. ISA Pharmaceuticals Business Overview
Table 136. ISA Pharmaceuticals Anal and Colorectal Cancer Product
Table 137. ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 138. ISA Pharmaceuticals Recent Development
Table 139. Merck Company Details
Table 140. Merck Business Overview
Table 141. Merck Anal and Colorectal Cancer Product
Table 142. Merck Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 143. Merck Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 147. Authors List of This Report
List of Figures
Figure 1. Anal and Colorectal Cancer Picture
Figure 2. Global Anal and Colorectal Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anal and Colorectal Cancer Market Share by Type: 2024 VS 2031
Figure 4. Surgery Features
Figure 5. Radiation therapy Features
Figure 6. Colorectal cancer chemotherapy Features
Figure 7. Targeted therapy Features
Figure 8. Immunotherapy Features
Figure 9. Global Anal and Colorectal Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Anal and Colorectal Cancer Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Ambulatory surgery centers Case Studies
Figure 13. Cancer research centers Case Studies
Figure 14. Anal and Colorectal Cancer Report Years Considered
Figure 15. Global Anal and Colorectal Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Anal and Colorectal Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Anal and Colorectal Cancer Market Share by Region: 2024 VS 2031
Figure 18. Global Anal and Colorectal Cancer Market Share by Players in 2024
Figure 19. Global Top Anal and Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anal and Colorectal Cancer as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Anal and Colorectal Cancer Revenue in 2024
Figure 21. North America Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Anal and Colorectal Cancer Market Share by Country (2020-2031)
Figure 23. United States Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Anal and Colorectal Cancer Market Share by Country (2020-2031)
Figure 27. Germany Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Anal and Colorectal Cancer Market Share by Region (2020-2031)
Figure 35. China Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Anal and Colorectal Cancer Market Share by Country (2020-2031)
Figure 43. Mexico Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Anal and Colorectal Cancer Market Share by Country (2020-2031)
Figure 47. Turkey Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abbott Diagnostics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 51. Advaxis Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 53. Amgen Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 54. Atara Biotherapeutics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 55. Bayer Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 56. Metabiomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 57. Beckman Coulter Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 58. BeiGene Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 60. Clinical Genomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 61. EDP Biotech Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 62. Eli Lilly Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 63. Epigenomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 64. Exact Sciences Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 65. Genomictree Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 66. Immunovaccine Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 67. ISA Pharmaceuticals Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 68. Merck Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Anal and Colorectal Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation therapy
Table 4. Key Players of Colorectal cancer chemotherapy
Table 5. Key Players of Targeted therapy
Table 6. Key Players of Immunotherapy
Table 7. Global Anal and Colorectal Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Anal and Colorectal Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Anal and Colorectal Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Anal and Colorectal Cancer Market Share by Region (2020-2025)
Table 11. Global Anal and Colorectal Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Anal and Colorectal Cancer Market Share by Region (2026-2031)
Table 13. Anal and Colorectal Cancer Market Trends
Table 14. Anal and Colorectal Cancer Market Drivers
Table 15. Anal and Colorectal Cancer Market Challenges
Table 16. Anal and Colorectal Cancer Market Restraints
Table 17. Global Anal and Colorectal Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Anal and Colorectal Cancer Market Share by Players (2020-2025)
Table 19. Global Top Anal and Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anal and Colorectal Cancer as of 2024)
Table 20. Ranking of Global Top Anal and Colorectal Cancer Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Anal and Colorectal Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Anal and Colorectal Cancer, Headquarters and Area Served
Table 23. Global Key Players of Anal and Colorectal Cancer, Product and Application
Table 24. Global Key Players of Anal and Colorectal Cancer, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anal and Colorectal Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Anal and Colorectal Cancer Revenue Market Share by Type (2020-2025)
Table 28. Global Anal and Colorectal Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Anal and Colorectal Cancer Revenue Market Share by Type (2026-2031)
Table 30. Global Anal and Colorectal Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Anal and Colorectal Cancer Revenue Market Share by Application (2020-2025)
Table 32. Global Anal and Colorectal Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Anal and Colorectal Cancer Revenue Market Share by Application (2026-2031)
Table 34. North America Anal and Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Anal and Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Anal and Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Anal and Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Anal and Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Anal and Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Anal and Colorectal Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Anal and Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Anal and Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Anal and Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Anal and Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abbott Diagnostics Company Details
Table 50. Abbott Diagnostics Business Overview
Table 51. Abbott Diagnostics Anal and Colorectal Cancer Product
Table 52. Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 53. Abbott Diagnostics Recent Development
Table 54. Advaxis Company Details
Table 55. Advaxis Business Overview
Table 56. Advaxis Anal and Colorectal Cancer Product
Table 57. Advaxis Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 58. Advaxis Recent Development
Table 59. Abbott Company Details
Table 60. Abbott Business Overview
Table 61. Abbott Anal and Colorectal Cancer Product
Table 62. Abbott Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 63. Abbott Recent Development
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Anal and Colorectal Cancer Product
Table 67. Amgen Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. Atara Biotherapeutics Company Details
Table 70. Atara Biotherapeutics Business Overview
Table 71. Atara Biotherapeutics Anal and Colorectal Cancer Product
Table 72. Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 73. Atara Biotherapeutics Recent Development
Table 74. Bayer Company Details
Table 75. Bayer Business Overview
Table 76. Bayer Anal and Colorectal Cancer Product
Table 77. Bayer Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 78. Bayer Recent Development
Table 79. Metabiomics Company Details
Table 80. Metabiomics Business Overview
Table 81. Metabiomics Anal and Colorectal Cancer Product
Table 82. Metabiomics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 83. Metabiomics Recent Development
Table 84. Beckman Coulter Company Details
Table 85. Beckman Coulter Business Overview
Table 86. Beckman Coulter Anal and Colorectal Cancer Product
Table 87. Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 88. Beckman Coulter Recent Development
Table 89. BeiGene Company Details
Table 90. BeiGene Business Overview
Table 91. BeiGene Anal and Colorectal Cancer Product
Table 92. BeiGene Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 93. BeiGene Recent Development
Table 94. Boehringer Ingelheim Company Details
Table 95. Boehringer Ingelheim Business Overview
Table 96. Boehringer Ingelheim Anal and Colorectal Cancer Product
Table 97. Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 98. Boehringer Ingelheim Recent Development
Table 99. Clinical Genomics Company Details
Table 100. Clinical Genomics Business Overview
Table 101. Clinical Genomics Anal and Colorectal Cancer Product
Table 102. Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 103. Clinical Genomics Recent Development
Table 104. EDP Biotech Company Details
Table 105. EDP Biotech Business Overview
Table 106. EDP Biotech Anal and Colorectal Cancer Product
Table 107. EDP Biotech Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 108. EDP Biotech Recent Development
Table 109. Eli Lilly Company Details
Table 110. Eli Lilly Business Overview
Table 111. Eli Lilly Anal and Colorectal Cancer Product
Table 112. Eli Lilly Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 113. Eli Lilly Recent Development
Table 114. Epigenomics Company Details
Table 115. Epigenomics Business Overview
Table 116. Epigenomics Anal and Colorectal Cancer Product
Table 117. Epigenomics Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 118. Epigenomics Recent Development
Table 119. Exact Sciences Company Details
Table 120. Exact Sciences Business Overview
Table 121. Exact Sciences Anal and Colorectal Cancer Product
Table 122. Exact Sciences Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 123. Exact Sciences Recent Development
Table 124. Genomictree Company Details
Table 125. Genomictree Business Overview
Table 126. Genomictree Anal and Colorectal Cancer Product
Table 127. Genomictree Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 128. Genomictree Recent Development
Table 129. Immunovaccine Company Details
Table 130. Immunovaccine Business Overview
Table 131. Immunovaccine Anal and Colorectal Cancer Product
Table 132. Immunovaccine Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 133. Immunovaccine Recent Development
Table 134. ISA Pharmaceuticals Company Details
Table 135. ISA Pharmaceuticals Business Overview
Table 136. ISA Pharmaceuticals Anal and Colorectal Cancer Product
Table 137. ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 138. ISA Pharmaceuticals Recent Development
Table 139. Merck Company Details
Table 140. Merck Business Overview
Table 141. Merck Anal and Colorectal Cancer Product
Table 142. Merck Revenue in Anal and Colorectal Cancer Business (2020-2025) & (US$ Million)
Table 143. Merck Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 147. Authors List of This Report
List of Figures
Figure 1. Anal and Colorectal Cancer Picture
Figure 2. Global Anal and Colorectal Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anal and Colorectal Cancer Market Share by Type: 2024 VS 2031
Figure 4. Surgery Features
Figure 5. Radiation therapy Features
Figure 6. Colorectal cancer chemotherapy Features
Figure 7. Targeted therapy Features
Figure 8. Immunotherapy Features
Figure 9. Global Anal and Colorectal Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Anal and Colorectal Cancer Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Ambulatory surgery centers Case Studies
Figure 13. Cancer research centers Case Studies
Figure 14. Anal and Colorectal Cancer Report Years Considered
Figure 15. Global Anal and Colorectal Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Anal and Colorectal Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Anal and Colorectal Cancer Market Share by Region: 2024 VS 2031
Figure 18. Global Anal and Colorectal Cancer Market Share by Players in 2024
Figure 19. Global Top Anal and Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anal and Colorectal Cancer as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Anal and Colorectal Cancer Revenue in 2024
Figure 21. North America Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Anal and Colorectal Cancer Market Share by Country (2020-2031)
Figure 23. United States Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Anal and Colorectal Cancer Market Share by Country (2020-2031)
Figure 27. Germany Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Anal and Colorectal Cancer Market Share by Region (2020-2031)
Figure 35. China Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Anal and Colorectal Cancer Market Share by Country (2020-2031)
Figure 43. Mexico Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Anal and Colorectal Cancer Market Share by Country (2020-2031)
Figure 47. Turkey Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Anal and Colorectal Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abbott Diagnostics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 51. Advaxis Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 53. Amgen Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 54. Atara Biotherapeutics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 55. Bayer Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 56. Metabiomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 57. Beckman Coulter Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 58. BeiGene Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 60. Clinical Genomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 61. EDP Biotech Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 62. Eli Lilly Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 63. Epigenomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 64. Exact Sciences Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 65. Genomictree Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 66. Immunovaccine Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 67. ISA Pharmaceuticals Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 68. Merck Revenue Growth Rate in Anal and Colorectal Cancer Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232